|
1
|
Schreiber F, Kuschel JN, Klai M, Chahem C, Arndt P, Perosa V, Assmann A, Dörner M, Luchtmann M, Meuth SG, Vielhaber S, Henneicke S, Schreiber S. Blend Sign and Haemorrhage Location and Volume Predict Late Recurrence and Mortality in Intracerebral Haemorrhage Patients. J Clin Med 2023; 12:6131. [PMID: 37834774 PMCID: PMC10573360 DOI: 10.3390/jcm12196131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2023] [Revised: 09/12/2023] [Accepted: 09/19/2023] [Indexed: 10/15/2023] Open
Abstract
BACKGROUND Studies on risk factors for primary intracerebral haemorrhage (ICH) focus on short-term predictive values of distinct clinical parameters or computed tomography (CT) markers and disregard the others. We, therefore, studied independent predictive values of demographic, clinical, and CT markers regarding ICH expansion, late ICH recurrence, and late mortality. METHODS In a retrospective study of 288 patients with primary ICH, ICH localization (158 lobar, 81 deep, and 49 cerebellar), volume, blend sign, spot sign, finger-like projections, and subarachnoid haemorrhages were evaluated. ICH localization-specific differences for demographic (age, sex), clinical parameters (vascular risk factors, antiplatelet, and anticoagulation therapy), and CT markers were evaluated using logistic regression. We applied Cox proportional hazards modelling using these parameters to predict risk factors for ICH expansion, late ICH recurrence, and late mortality. RESULTS The blend sign in lobar ICH relates to increased risk of ICH expansion (HR2.3), late ICH recurrence (HR2.3), and mortality (HR1.6). Age, conditions requiring antiplatelet medication, deep ICH localization, volume, and blend sign represented the most important independent factors impacting overall mortality. CONCLUSIONS Blend sign at baseline ICH is a manifestation of underlying detrimental vascular processes that signal increased ICH expansion risk, although is also indicative of long-term risks for late recurrent ICH and late mortality.
Collapse
Affiliation(s)
- Frank Schreiber
- Department of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany; (F.S.); (J.-N.K.); (M.K.); (C.C.); (P.A.); (V.P.); (S.V.); (S.H.)
- German Center for Neurodegenerative Diseases (DZNE), 39120 Magdeburg, Germany;
| | - Jan-Niklas Kuschel
- Department of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany; (F.S.); (J.-N.K.); (M.K.); (C.C.); (P.A.); (V.P.); (S.V.); (S.H.)
| | - Marwa Klai
- Department of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany; (F.S.); (J.-N.K.); (M.K.); (C.C.); (P.A.); (V.P.); (S.V.); (S.H.)
| | - Christian Chahem
- Department of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany; (F.S.); (J.-N.K.); (M.K.); (C.C.); (P.A.); (V.P.); (S.V.); (S.H.)
| | - Philipp Arndt
- Department of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany; (F.S.); (J.-N.K.); (M.K.); (C.C.); (P.A.); (V.P.); (S.V.); (S.H.)
- German Center for Neurodegenerative Diseases (DZNE), 39120 Magdeburg, Germany;
| | - Valentina Perosa
- Department of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany; (F.S.); (J.-N.K.); (M.K.); (C.C.); (P.A.); (V.P.); (S.V.); (S.H.)
- J. Philip Kistler Stroke Research Center, Massachusetts General Hospital, Boston, MA 02114, USA
| | - Anne Assmann
- Department of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany; (F.S.); (J.-N.K.); (M.K.); (C.C.); (P.A.); (V.P.); (S.V.); (S.H.)
| | - Marc Dörner
- German Center for Neurodegenerative Diseases (DZNE), 39120 Magdeburg, Germany;
- Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland
| | - Michael Luchtmann
- Department of Neurosurgery, Otto-von-Guericke University, 39120 Magdeburg, Germany
| | - Sven Günther Meuth
- Department of Neurology, Heinrich-Heine-University, 40225 Düsseldorf, Germany;
| | - Stefan Vielhaber
- Department of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany; (F.S.); (J.-N.K.); (M.K.); (C.C.); (P.A.); (V.P.); (S.V.); (S.H.)
- Center for Behavioral Brain Sciences (CBBS), Otto-von-Guericke University, 39106 Magdeburg, Germany
| | - Solveig Henneicke
- Department of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany; (F.S.); (J.-N.K.); (M.K.); (C.C.); (P.A.); (V.P.); (S.V.); (S.H.)
- German Center for Neurodegenerative Diseases (DZNE), 39120 Magdeburg, Germany;
| | - Stefanie Schreiber
- Department of Neurology, Otto-von-Guericke University, 39120 Magdeburg, Germany; (F.S.); (J.-N.K.); (M.K.); (C.C.); (P.A.); (V.P.); (S.V.); (S.H.)
- German Center for Neurodegenerative Diseases (DZNE), 39120 Magdeburg, Germany;
- Center for Behavioral Brain Sciences (CBBS), Otto-von-Guericke University, 39106 Magdeburg, Germany
| |
Collapse
|
|
2
|
Prognostic Significance of the Combined Score of Plasma Fibrinogen and Neutrophil-Lymphocyte Ratio in Patients with Spontaneous Intracerebral Hemorrhage. DISEASE MARKERS 2022; 2021:7055101. [PMID: 35003392 PMCID: PMC8731292 DOI: 10.1155/2021/7055101] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/17/2021] [Accepted: 12/01/2021] [Indexed: 02/05/2023]
Abstract
Background The combination of plasma fibrinogen and neutrophil to lymphocyte ratio (F-NLR) score is a novel inflammatory marker constituted by peripheral blood fibrinogen concentration and neutrophil to lymphocyte ratio. In the current study, we aim to explore the relationship between admission F-NLR score and intracerebral hemorrhage (ICH) and assess its prognostic predictive ability in ICH patients. Methods The original cohort was consecutively recruited from August 2014 to September 2017, and the validation cohort was consecutively recruited between October 2018 and March 2020. The primary outcomes were 3-month functional outcome and 1-month mortality. All statistical analyses were performed using SPSS and R software. Results A total of 431 and 251 ICH patients were included in original cohort and validation cohort, respectively. In the original cohort, F-NLR score could independently predict the 3-month functional outcome (adjusted OR 2.013, 95% CI 1.316-3.078, p = 0.001) and 1-month mortality (adjusted OR 3.036, 95% CI 1.965-4.693, p < 0.001). Receiver operation characteristic (ROC) analyses and predictive model comparison indicated that F-NLR score had a stronger predictive ability in the 3-month outcome and 1-month mortality. Validation cohort verified the results. Conclusion F-NLR score was an independent indicator for both the 3-month functional outcome and 1-month mortality, and its prognostic predictive ability was superior to fibrinogen and NLR in both the original and the validation cohort.
Collapse
|